BlackRock Institutional Trust’s THERAGENICS CORP TGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-1,305,902
Closed -$2.85M 4121
2013
Q3
$2.85M Sell
1,305,902
-5,536
-0.4% -$11.8K ﹤0.01% 2969
2013
Q2
$2.71M Buy
+1,311,438
New +$2.35M ﹤0.01% 2946

BlackRock Institutional Trust's TGX Position: Q4 2013 in Review

BlackRock Institutional Trust sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 1,305,902 shares — an estimated $2.85M sold.

BlackRock Institutional Trust first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $2.85M in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • BlackRock Institutional Trust reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • BlackRock Institutional Trust sold 1,305,902 THERAGENICS CORP shares in Q4 2013, an estimated $2.85M.
  • BlackRock Institutional Trust first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • BlackRock Institutional Trust's THERAGENICS CORP position peaked at $2.85M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on BlackRock Institutional Trust's 13F filing for Q4 2013, filed 12 Feb 2014.